18-Hydroxytritriacontan-16-one

CAS : 97191-42-9

Ref. 3D-XDA19142

Informations sur le produit

• Nom: 18-Hydroxytritriacontan-16-one
• Synonymes: 16-Tritriacontanone, 18-hydroxy-, 18-Hydroxy-16-tritriacontanone

Description

18-Hydroxytritriacontan-16-one is a potent anticancer agent that has been shown to exhibit inhibitory activity towards tumor cells. It acts as a protein kinase inhibitor, which can lead to cell cycle arrest and apoptosis in cancer cells. This compound has demonstrated significant antitumor activity against various types of cancers, making it a promising candidate for cancer treatment. Its mechanism of action involves the inhibition of several key enzymes involved in cell proliferation and survival, including cyclin-dependent kinases and protein kinases. Studies have also shown that 18-Hydroxytritriacontan-16-one exhibits selective toxicity towards cancer cells while sparing normal cells, making it a potentially safer alternative to traditional chemotherapy drugs. Overall, this compound shows great promise as an effective anticancer agent with broad-spectrum activity against many different types of tumors.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 494.9 g/mol
• Formule: C₃₃H₆₆O₂
• Degré de pureté: Min. 95%